The L-arginine-nitric oxide pathway: Role in atherosclerosis and therapeutic implications

Atherosclerosis

Volumn 127, Issue 1, 1996, Pages 1-11

  Böger, Rainer H ^a,b   Bode Böger, Stefanie M ^a   Frölich, Jürgen C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; L arginine; nitrix oxide; therapeutic implications

Indexed keywords

ARGININE; NITRIC OXIDE;

ATHEROSCLEROSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; ARGININE; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; VASODILATION;

EID: 0030588667     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05953-9     Document Type: Review

References (120)

1. [1] Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
2. [2] Furchgott RF. The role of the endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 1984;24:175-197.
3. [3] Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endotheliun-derived relaxing factor. Nature 1987;327:524-526.
4. [4] Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-666.
5. [5] Moncada S, Higgs EA. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
6. [6] Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrom P-450 reductase. Nature 1991;351:714-718.
7. [7] Pollock JS, Förstermann U, Mitchell JA, Warner TD, Schmidt HHHW, Nakane M, Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991;88;10480-10484.
8. [8] Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitrid oxide synthase in vitro and in vivo. Br J Pharmacol 1990;101:746-752.
9. [9] Böger RH, Bode-Böger SM, Gerecke U, Frölich JC. Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulate urinary nitrate and cyclic GMP excretion in rats - correlation with vascular reactivity. Cardiovasc Res 1994;28:494-499.
10. [10] Mayer B, John M, Heinzel B, Werner ER, Wachter H, Schultz G, Böhme E. Brain nitric oxide synthase is a biopterin- and flavin-containing multi-functional oxido-reductase. FEBS Lett 1991;288:187-191.
11. [11] Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 1991;88:7773-7778.
12. [12] Förstermann U, Closs EI, Pollock JS et al. Nitric oxide synthase isoenzymes. Characterization, purification, molecular cloning, and functions. Hypertension 1994;23:1121-1131.
13. [13] Griffith TM, Edward DH, Lewis MJ, Newby AC, Henderson AH. The nature of the endothetium-derived vascular relaxant factor. Nature 1984;308:645-647.
14. [14] Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
15. [15] Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 1990;30:535-560.
16. [16] Wennmalrn A, Benthin G, Edlund A et al. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circulation 1993;73:1121-1127.
17. [17] Tolins JP, Palmer RMJ, Moncada S, Raij L. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol 1990;27:H655-H662.
18. 2 as internal standard. Biol Mass Spectrom 1992;21:97-102.
19. 3 excretion in the urine as an indicator of endothelium-derived relaxing factor during elevation of blood pressure. Clin Sci 1992;82:631-634.
20. [20] Bode-Böger SM, Böger RH, Creutzig A et al. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci 1994;87:303-310.
21. 3 excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-NAME in rats. Clin Exp Pharmacol Physiol 23:11-15.
22. [22] Stichtenoth DO, Gutzki FM, Tsikas D et al. Increased urinary nitrate excretion as an index of inflammatory activity in adjuvant arthritis. Ann Rheum Dis 1994;53:547-549.
23. [23] Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
24. [24] Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. FEBS Lett 1994;350:9-12.
25. [25] Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989;86:3375-3378.
26. [26] Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 1986;8:37-44.
27. [27] Cooke JP, Rossitch E, Andon NA, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 1991;88:1663-1671.
28. [28] Bollinger A. Periphere Zirkulation. In: Siegenthaler W (ed). Klinische Pathophysiologie. 5th edn, Stuttgart: Thieme 1982, pp. 756-794.
29. [29] Berne RM, Winn HR, Knabb RM, Ely SW, Rubio R. Blood flow regulation by adenosine in heart, brain, and skeletal muscle. In: Berne RM, Rail TW, Rubio R (eds). Regulatory Function of Adenosine. Boston: Martinus Nijhoff Publishing, 1983. pp. 293-317.
30. [30] Carlsson I, Wennmalm A. Effect of different prostaglandin synthesis inhibitors on post-occlusive blood flow in human forearm. Prostaglandins 1983;26:241-252.
31. [31] Joannides R, Haefeli WE, Under L, Richard V, Bakkali EH, Thuillez C, Lüscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-1319.
32. [32] Gilligan DM, Panza JA, Kilcoyne CM, Waclawiw MA, Casino PR, Ouyyumi AA. Contribution of endotheliurn-derived nitric oxide to exercise-induced vasodilation. Circulation 1994;90:2853-2858.
33. [33] Wang J, Wolin MS, Hintze TH. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary arteries in conscious dogs. Circ Res 1993;73:829-838.
34. [34] Endo T, Imaizumi T, Tagawa T, Shiramoto M, Ando S, Takeshita A. Role of nitric oxide in exercise-induced vasodilation of the forearm. Circulation 1994;90:2886-2890.
35. [35] Bode-Böger SM, Böger RH, Schröder EP, Frölich JC. Exercise increases systemic NO production in man. J Cardiovasc Risk 1994;1:173-178.
36. [36] Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular endothelial nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1994;74:349-353.
37. [37] Förstermann U, Mügge A, Bode SM, Frölich JC. Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids. Circ Res 1988;63:306-312.
38. [38] Förstermann U, Mügge A, Alheid U, Haverich A, Frölich JC. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res 1988;62:185-190.
39. [39] Kaul S, Waack BJ, Padgeff RC, Brooks RM, Heistad DD. Altered vascular responses to platelets from hypercholesterolemic humans. Circ Res 1993;72:737-743.
40. [40] Guerra Rjr, Brotherton AFA, Goodwin PJ, Clark CR, Armstrong ML, Harrison DG. Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: implications for altered autocrine and paracrine function of EDRF. Blood Vessels 1989;26:300-314.
41. [41] Girerd XJ, Hirsch AT, Cooke JP, Dzau VJ, Creager MA. L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res 1990;67:1301-1308.
42. [42] Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 1991;83:1057-1062.
43. [43] Habib JB, Bossaller C, Wells S, Williams C, Morriseff JD, Henry PD. Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110. Circ Res 1986;58:305-309.
44. [44] Verbeuren TJ, Jordaens FH, Van Hove CE, Van Hoyndonck AE, Herman AG. Release and vascular activity of endothelum-derived relaxing factor in atherosclerotic rabbit aorta. Eur J Pharmacol 1990;191:173-184.
45. [45] Osborne JA, Siegman MJ, Sedar AW, Mooers SU, Lefer AM. Lack of endothelium-dependent relaxation on coronary resistance arteries of cholesterol-fed rabbits. Am J Physiol 1989;256:C591-C597.
46. [46] Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991;338:1546-1550.
47. [47] Vita JA, Treasure CB, Nabel EG, Fish RD, McLenachan JM, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-497.
48. [48] Otsuji S, Nakajima O, Waku S et al. Attenuation of acetylcholine-induced vasoconstriction by L-arginine is related to the progression of atherosclerosis. Am Heart J 1995;129:1094-1100.
49. [49] Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992;90:1248-1253.
50. [50] Arcaro G, Zenere BM, Travia D et al. Non-invasive detection on early endothelial dysfunction in hypercholesterolemic subjects. Atherosclerosis 1995;114:247-254.
51. [51] Sneddon JM, Vane JR. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA 1988;85:2800-2804.
52. [52] Vanhouffe PM, Shirnokawa H. Endothelium-derived relaxing factor(s) and coronary vasospasm. Circulation 1989;80:1-9.
53. [53] Kubes P, Suzuki M, Ganger DN. Nitric oxide:an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-4655.
54. [54] Lefer AM, Ma XI. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb 1993;13:771-776.
55. [55] Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994;89:2176-2182.
56. [56] Ross R. The pathogenesis of atherosclerosis:a perspective for the 1990s. Nature 1993;362:801-809.
57. [57] Ludwig PW, Hunninghake DB, Hoidal JR. Increased leukocyte oxidative metabolism in hyperlipoprotemaemia. Lancet 1982;ii:348-350.
58. [58] Mügge A, Brandes R, Böger RH et al. Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol 1994;24:994-998.
59. [59] Steinbrecher UP. Role of superoxide in endothelial-cell modification of low-density lipoproteins. Biochem Biophys Acta 1988;959:20-30.
60. [60] Stary HC, Chandler AB, Glagow S et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. Circulation 1994;89:2462-2478.
61. [61] Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cells function. FASEB J 1992;6:2591-2599.
62. [62] Katsuda S, Coltrera MD, Ross R, Gown AM. Human atherosclerosis. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am J Pathol 1993;142:1787-1793.
63. [63] Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992;90:1116-1121.
64. [64] Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-1777.
65. [65] Nakaki T, Nakayama M, Kato R. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol 1990;189:347-353.
66. [66] Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 1990;336:897-900.
67. [67] Minor RL, Myers PR, Guerra R, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 1990;86:2109-2116.
68. [68] Böger RH, Bode-Böger SM, Mügge A et al. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 1995;117:273-284.
69. [69] Greene B, Pacitti AJ, Souba WW. Characterization of L-arginine transport by pulmonary artery endothelial cells. Am J Physiol 1993;264:L351-L356.
70. [70] Yu X, Li Y, Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life Sci 1994;54:753-758.
71. [71] Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992;20(Suppl 12):S60-S62.
72. [72] Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-densitiy lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995;270:319-324.
73. [73] Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;91:2546-2551.
74. [74] Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radical Res Comms 1993;18:195-199.
75. [75] Beckmann JS, Ye YZ, Anderson PG et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 1994;375:81-88.
76. [76] Henning B, Chow CK. Lipid peroxidation and endothelial cell injury:implications in atherosclerosis. Free Radical Biol Med 1988;4:99-106.
77. [77] Matsubara T, Ziff M. Superoxide anion release by human endothelial cells: synergism between a phorbol ester and a calcium ionophore. J Cell Physiol 1986;127:207-210.
78. [78] Niu XF, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 1994;74:1133-1140.
79. [79] Pritchard KA, Groszek L, Smalley DM et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 1995;77:510-518.
80. [80] Witzurn JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-1792.
81. [81] Simon BC, Cunningham LD, Cohen RA. Oxidized low-density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 1990;86:75-79.
82. [82] Plane F, Bruckdorfer KR, Kerr P, Steuer A, Jacobs M. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Br J Pharmacol 1992;105:216-222.
83. [83] Liao L, Granger DN. Modulation of oxidized low-density lipoprotein-induced microvascular dysfunction by nitric oxide. Am J Physiol 1995;268:H1643-H1650.
84. [84] Collins T. Endothelial nuclear factor-KB and the initiation of the atherosclerotic lesion. Lab Invest 1993;5:499-508.
85. [85] Ueda A, Okuda K, Ohno S et al. NF-KB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994;153:2052-2063.
86. [86] Marui N, Offerman MK, Swerlick R et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993;92:1866-1874.
87. [87] Xie Q, Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukocyte Biol 1994;56:576-582.
88. [88] Zeiher AM, Schray-Utz B, Busse R. NO modulates monocyte chemoattractant protein-1 in human endothelial cells: implications for the pathogenesis of atherosclerosis. Circulation 1993;88(Suppl): 1-367, (Abstract).
89. [89] Bossaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987;79:170-174.
90. [90] Shimokawa H, Flavahan NA, Vanhoutte PM. Loss of endothelial pertussis toxin-sensitive G-protein function in atherosclerotic porcine coronary arteries. Circulation 1991;83:652-660.
91. [91] Casino PR, Kilcoyne CM, Cannon RO, Quyyumi AA, Panza JA. Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor. Am J Cardiol 1995;75:40-44.
92. 2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension 1990;15:475-481.
93. [93] Tanner FC, Boulanger CM, Lüscher TF. Endothelium-derived nitric oxide, endothelin, and platelet vessel wall interaction: alterations in hypercholesterolemia and atherosclerosis. Semin Thromb Hemost 1993;19:167-175.
94. [94] Cosentino F, Sill JC, Katusic ZS. Role of supoeroxide unions in the mediation of endothelium-dependent contractions. Hypertension 1994;23:229-235.
95. [95] Goligorsky MS, Tsukahara H, Magazine H, Andersen U, Malik AB, Bahou WF. Termination of endothelin signaling: role of nitric oxide. J Cell Physiol 1994;158:485-494.
96. [96] Brunner F, Stessel H, Kukovetz WR. Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion. FEBS Lett 1995;376:262-266.
97. [97] Hirata Y, Emori T, Eguchi S et al. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993;91:1367-1373.
98. [98] Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987;80:1808-1811.
99. [99] Osborne JA, Lento PH, Siegfried MR, Stahl GL, Fusman B, Lefer AM. Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment. J Clin Invest 1989;83:465-473.
100. [100] Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherosclerotic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992;90:1168-1172.
101. G-hydroxy-L-arginine-nitric oxide adduct. Proc Natl Acad Sci USA 1995;92:4671-4675.
102. [102] McNamara DB, Bedi B, Aurora H, Tena L, Ignarro LJ, Kadowitz PJ, Akers DL. L-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem Biophys Res Commun 1993;193:291-296.
103. [103] Tarry WC, Makhoul RG. L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty. Arterioscler Thromb 1994;14:938-943.
104. [104] Singer AH, Tsao PS, Wang BY, Bloch DA, Cooke JP. Discordant effects of dietary L-arginine on vascular structure and reactivity in hypercholesterolemic rabbits. J Cardiovasc Pharmacol 1995;25:710-716.
105. [105] Kanno K, Hirata Y, Emori T et al. L-arginine infusion induces hypotension and diuresis/natriuresis concomitant with increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 1992;19:619-625.
106. [106] Bode-Böger SM, Böger RH, Alfke H et al. L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. Circulation 1996;93:85-90.
107. [107] Imaizumi T, Hiooka Y, Masaki H et al. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 1992;20:511-517.
108. [108] Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients. J Am Coll Cardiol 1994;23:844-850.
109. [109] D'Orleans-Juste P, Mitchell JA, Wood EG, Hecker M, Vane JR. Comparison of the release of vasoactive factors from venous and arterial bovine cultured endothelial cells. Can J Physiol Pharmacol 1992;70:687-694.
110. [110] Bode-Böger SM, Böger RH, Kienke S, Junker W, Frölich JC. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 1996;219:598-603.
111. [111] Calver A, Collier J, Valiance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci 1991;81:695-700.
112. [112] MacAllister RJ, Calver AL, Collier J et al. Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect? Clin Sci 1995;89:183-190.
113. [113] Pedrinelli R, Ebel M, Catapano G et al. Pressor, renal and endocrine effects of L-arginine in essential hypertensives. Eur J Clin Pharmacol 1995;48:195-201.
114. [114] Li G, Regunathan S, Barrow CJ, Eshragi J, Cooper R, Reis DJ. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994;263:966-969.
115. [115] Jun T, Wennmalm A. L-arginine-induced hypotension in the rat: evidence that NO synthesis is not involved. Acta Physiol Scand 1994;152:385-390.
116. G-Methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. Circ Res 1992;70:607-611.
117. [117] Radomski MW, Palmer RMJ, Moncada S. Characterization of the L-arginine: nitric oxide pathway in human platelets. Br J Pharmacol 1990;101:325-328.
118. [118] Randall MD, Grifith TM. EDRF plays central role in collateral flow after arterial occlusion in rabbit ear. Am J Physiol 1992;263:H752-H760.
119. [119] Randall MD, Ujiie H, Griffith TM. L-arginine reverses the impairment of nitric oxide-dependent collateral perfusion in dietary-induced hypercholesterolemia in the rabbit. Clin Sci 1994;87:53-59.
120. [120] Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett 1993;334:170-174.